A phase I dose escalation study of AUY922, a novel HSP90 inhibitor, in patients with advanced solid malignancies

被引：0
|
作者：
Sessa, C.
Sharma, S. K.
Britten, C. D.
Vogelzang, N. J.
Bhalla, K. N.
Mita, M. M.
Pluard, T. J.
Stiegler, P.
Quadt, C.
Shapiro, G. I.
机构：
[1] IOSI, Bellinzona, Switzerland
[2] Nevada Canc Inst, Las Vegas, NV USA
[3] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA
[4] Med Coll Georgia, Augusta, GA 30912 USA
[5] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[6] Washington Univ, Sch Med, St Louis, MO USA
[7] Novartis Pharmaceut, Florham Pk, NJ USA
[8] Novartis Pharmaceut, Basel, Switzerland
[9] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3532
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Demonstrating preclinical efficacy of AUY922, a novel Hsp90 inhibitor, alone and in combination with standard chemotherapy or radiation in esophageal adenocarcinoma
    Kosovec, Juliann
    Rotaloni, Christina
    Zaidi, Ali H.
    Komastu, Yoshihiro
    Kelly, Lori
    Matsui, Daisuke
    Waheed, Amine
    Hoppo, Toshitaka
    Jobe, Blair A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] Hsp90 inhibition by AUY922 as an effective treatment strategy against myxoid liposarcoma
    Steinmann, Sara
    Gali-Muhtasib, Hala
    Huebner, Kerstin
    Al-Halabi, Racha
    Abou Merhi, Raghida
    Aman, Pierre
    Agaimy, Abbas
    Haller, Florian
    Schneider-Stock, Regine
    CANCER LETTERS, 2015, 367 (02) : 147 - 156
  • [23] Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells
    Zitzmann, Kathrin
    Ailer, Galina
    Vlotides, George
    Spoettl, Gerald
    Maurer, Julian
    Goeke, Burkhard
    Beuschlein, Felix
    Auernhammer, Christoph J.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (06) : 1824 - 1832
  • [24] Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma
    Augello, Giuseppa
    Emma, Maria Rita
    Cusimano, Antonella
    Azzolina, Antonina
    Mongiovi, Sarah
    Puleio, Roberto
    Cassata, Giovanni
    Gulino, Alessandro
    Belmonte, Beatrice
    Gramignoli, Roberto
    Strom, Stephen C.
    McCubrey, James A.
    Montalto, Giuseppe
    Cervello, Melchiorre
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (10) : 2613 - 2624
  • [25] Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922
    Wang, Chun Yan
    Guo, Su Tang
    Wang, Jia Yu
    Yan, Xu Guang
    Farrelly, Margaret
    Zhang, Yuan Yuan
    Liu, Fen
    Yari, Hamed
    La, Ting
    Lei, Fu Xi
    Jin, Lei
    Zhang, Xu Dong
    Jiang, Chen Chen
    ONCOTARGET, 2016, 7 (31) : 49597 - 49610
  • [26] HSP90 inhibitor AUY922 can reverse Fulvestrant induced feedback reaction in human breast cancer cells
    Bai, Jingchao
    Zhou, Guanglin
    Qiu, Yufan
    Hu, Yunhui
    Liu, Jingjing
    Zhao, Jing
    Zhang, Sheng
    Zhang, Jin
    CANCER SCIENCE, 2017, 108 (06) : 1177 - 1184
  • [27] Novel Hsp90 Inhibitor NVP-AUY922 Radiosensitizes Prostate Cancer Cells
    Gandhi, N.
    Wild, A. T.
    Aziz, K.
    Chettiar, S.
    Gajula, R.
    Zeng, J.
    Herman, J.
    Deweese, T. L.
    Hales, R.
    Tran, P. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S178 - S178
  • [28] REACTIVATION OF ERK AND AKT CONFERS RESISTANCE OF MUTANT BRAF COLON CANCER CELLS TO THE HSP90 INHIBITOR AUY922
    Wang, Chun Yan
    Guo, Su Tang
    Wang, Jia Yu
    Yan, Xu Guang
    Farrelly, Margaret
    Zhang, Yuan Yuan
    Liu, Fen
    Yari, Hamed
    La, Ting
    Lei, Fu Xi
    Jin, Lei
    Zhang, Xu Dong
    Jiang, Chen Chen
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 33 - 33
  • [29] Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
    Gandhi, Nishant
    Wild, Aaron T.
    Chettiar, Sivarajan T.
    Aziz, Khaled
    Kato, Yoshinori
    Gajula, Rajendra P.
    Williams, Russell D.
    Cades, Jessica A.
    Annadanam, Anvesh
    Song, Danny
    Zhang, Yonggang
    Hales, Russell K.
    Herman, Joseph M.
    Armour, Elwood
    DeWeese, Theodore L.
    Schaeffer, Edward M.
    Tran, Phuoc T.
    CANCER BIOLOGY & THERAPY, 2013, 14 (04) : 347 - 356
  • [30] PHARMACODYNAMIC EFFECTS OF THE HEAT SHOCK PROTEIN 90 (HSP90) INHIBITOR, AUY922, IN HIGH-RISK, LOCALISED PROSTATE CANCER
    Zhang, A. Y.
    Butler, L. M.
    Stricker, P. D.
    Kench, J. G.
    Tilley, W. D.
    Sebastian, L.
    Stockler, M.
    Horvath, L.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 46 - 46
12345